Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00055484 · ClinicalTrials.gov registry record · Phase 2
A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache
A Phase 2 study, sponsored by Elan Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 204
- Enrollment target
NCT00055484: Completed Phase 2 study, sponsored by Elan Pharmaceuticals.
NCT00055484 is a Phase 2 study that has completed, run by Elan Pharmaceuticals. The registered enrollment target is 204 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (53% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00055484, a Phase 2 study, has completed, sponsored by Elan Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 204 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if zonisamide is effective as a preventative medication for individuals with migraine headache.
Interventions
- DRUG zonisamide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2002-03 |
| Est. Completion | 2003-05 |
| Phase | Phase 2 |
What the finished NCT00055484 record still lists
NCT00055484 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (53% higher).
The record links to 0 conditions, and to 1 intervention - of which zonisamide is the first listed.
NCT00055484 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00055484 about?
NCT00055484 is a clinical study titled "A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache". The purpose of this study is to determine if zonisamide is effective as a preventative medication for individuals with migraine headache.
What is the current status of trial NCT00055484?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 204 participants. The study started on 2002-03. Estimated completion is 2003-05.
What interventions are being tested in trial NCT00055484?
The interventions under investigation include: zonisamide (DRUG).
Who is sponsoring clinical trial NCT00055484?
This trial is sponsored by Elan Pharmaceuticals, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00055484's enrollment target sits among peer trials
204 299th of 2000 higher than 1,700 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia